NO953846L - (S)-alfa-fenyl-2-pyridinetanamin (S)-malat og dets anvendelse som legemiddel - Google Patents
(S)-alfa-fenyl-2-pyridinetanamin (S)-malat og dets anvendelse som legemiddelInfo
- Publication number
- NO953846L NO953846L NO953846A NO953846A NO953846L NO 953846 L NO953846 L NO 953846L NO 953846 A NO953846 A NO 953846A NO 953846 A NO953846 A NO 953846A NO 953846 L NO953846 L NO 953846L
- Authority
- NO
- Norway
- Prior art keywords
- malate
- alpha
- phenyl
- pyridinethanamine
- drug
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/GB1993/000689 WO1993020052A1 (en) | 1992-04-03 | 1993-04-01 | Enantiomeric 1-phenyl-2-(2-pyridinyl)ethylamine for the treatment of neurodegenerative disorders |
| GB939320273A GB9320273D0 (en) | 1993-04-01 | 1993-10-01 | Compound useful in therapy |
| PCT/GB1994/000651 WO1994022831A1 (en) | 1993-04-01 | 1994-03-29 | (s)-alpha-phenyl-2-pyridineethanamine (s)-malate and its use as a medicament |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO953846D0 NO953846D0 (no) | 1995-09-28 |
| NO953846L true NO953846L (no) | 1995-11-21 |
| NO304647B1 NO304647B1 (no) | 1999-01-25 |
Family
ID=26302299
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO951546A NO304647B1 (no) | 1993-04-01 | 1995-09-28 | (S)-alfa-fenyl-2-pyridinetanamin (S)-malat, farmas÷ytisk preparat inneholde denne forbindelsen og dens anvendelse til fremstilling av legemiddel |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP0691957B1 (no) |
| JP (1) | JP3023987B2 (no) |
| CN (1) | CN1047168C (no) |
| AT (1) | ATE156813T1 (no) |
| AU (1) | AU682348B2 (no) |
| CA (1) | CA2159478C (no) |
| DE (1) | DE69404974T2 (no) |
| DK (1) | DK0691957T3 (no) |
| DZ (1) | DZ1765A1 (no) |
| ES (1) | ES2105672T3 (no) |
| FI (1) | FI109018B (no) |
| GB (1) | GB9320273D0 (no) |
| GR (1) | GR3025081T3 (no) |
| IL (1) | IL109108A (no) |
| MA (1) | MA23154A1 (no) |
| NO (1) | NO304647B1 (no) |
| PH (1) | PH30950A (no) |
| SG (1) | SG48204A1 (no) |
| WO (1) | WO1994022831A1 (no) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE135206T1 (de) * | 1988-08-12 | 1996-03-15 | Astra Ab | Arylalkylamine und -amide mit krampflösender und nervenschützender wirkung |
| ZA942140B (en) * | 1993-04-01 | 1994-10-03 | Fisons Corp | Salt of (S)-alpha-phenyl-2-pyridineethanamine useful in therapy |
| SE9901340D0 (sv) * | 1999-04-15 | 1999-04-15 | Astra Pharma Prod | Novel process |
| SE9901338D0 (sv) * | 1999-04-15 | 1999-04-15 | Astra Pharma Prod | Novel process |
| DE10301650A1 (de) * | 2003-01-17 | 2004-07-29 | Johannes-Gutenberg-Universität Mainz | Medizinisch nützliche 1-Phenyl-2-aminomethylnaphthaline, Verfahren zu ihrer Herstellung, sie enthaltende Arzneimittel und deren Verwendung |
| EP2610246A1 (en) | 2008-12-24 | 2013-07-03 | AstraZeneca AB | Ethanamine compounds and methods of using the same |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3422191A (en) * | 1965-01-21 | 1969-01-14 | Synergistics Inc | Compositions and methods for tranquilization employing salts of n-morpholine ethanol |
| ATE135206T1 (de) * | 1988-08-12 | 1996-03-15 | Astra Ab | Arylalkylamine und -amide mit krampflösender und nervenschützender wirkung |
| JP2514855B2 (ja) * | 1990-08-08 | 1996-07-10 | キッセイ薬品工業株式会社 | 光学活性なアラニンアニリド誘導体の酸付加塩 |
| ES2115055T3 (es) * | 1992-04-03 | 1998-06-16 | Astra Ab | 1-fenil-2-(2-piridinil)etilamina enantiomera para el tratamiento de trastornos neurodegenerativos. |
-
1993
- 1993-10-01 GB GB939320273A patent/GB9320273D0/en active Pending
-
1994
- 1994-03-24 IL IL10910894A patent/IL109108A/en not_active IP Right Cessation
- 1994-03-29 WO PCT/GB1994/000651 patent/WO1994022831A1/en active IP Right Grant
- 1994-03-29 DE DE69404974T patent/DE69404974T2/de not_active Expired - Lifetime
- 1994-03-29 CA CA002159478A patent/CA2159478C/en not_active Expired - Lifetime
- 1994-03-29 PH PH48016A patent/PH30950A/en unknown
- 1994-03-29 SG SG1996007883A patent/SG48204A1/en unknown
- 1994-03-29 AT AT94911232T patent/ATE156813T1/de active
- 1994-03-29 AU AU63802/94A patent/AU682348B2/en not_active Expired
- 1994-03-29 EP EP94911232A patent/EP0691957B1/en not_active Expired - Lifetime
- 1994-03-29 DK DK94911232.0T patent/DK0691957T3/da active
- 1994-03-29 ES ES94911232T patent/ES2105672T3/es not_active Expired - Lifetime
- 1994-03-29 JP JP6521814A patent/JP3023987B2/ja not_active Expired - Lifetime
- 1994-03-30 DZ DZ940029A patent/DZ1765A1/fr active
- 1994-04-01 MA MA23459A patent/MA23154A1/fr unknown
- 1994-04-01 CN CN94103739A patent/CN1047168C/zh not_active Expired - Lifetime
-
1995
- 1995-09-28 NO NO951546A patent/NO304647B1/no not_active IP Right Cessation
- 1995-09-29 FI FI954645A patent/FI109018B/fi not_active IP Right Cessation
-
1997
- 1997-10-17 GR GR970402722T patent/GR3025081T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PH30950A (en) | 1997-12-23 |
| CN1047168C (zh) | 1999-12-08 |
| SG48204A1 (en) | 1998-04-17 |
| IL109108A (en) | 1999-01-26 |
| GR3025081T3 (en) | 1998-01-30 |
| FI109018B (fi) | 2002-05-15 |
| FI954645A (fi) | 1995-11-29 |
| JPH08508292A (ja) | 1996-09-03 |
| AU682348B2 (en) | 1997-10-02 |
| DE69404974D1 (de) | 1997-09-18 |
| AU6380294A (en) | 1994-10-24 |
| JP3023987B2 (ja) | 2000-03-21 |
| CA2159478A1 (en) | 1994-10-13 |
| NO304647B1 (no) | 1999-01-25 |
| CA2159478C (en) | 2005-01-25 |
| EP0691957A1 (en) | 1996-01-17 |
| DE69404974T2 (de) | 1997-12-18 |
| GB9320273D0 (en) | 1993-11-17 |
| IL109108A0 (en) | 1994-06-24 |
| EP0691957B1 (en) | 1997-08-13 |
| ES2105672T3 (es) | 1997-10-16 |
| ATE156813T1 (de) | 1997-08-15 |
| NO953846D0 (no) | 1995-09-28 |
| DK0691957T3 (da) | 1997-10-27 |
| CN1098095A (zh) | 1995-02-01 |
| MA23154A1 (fr) | 1994-12-31 |
| DZ1765A1 (fr) | 2002-02-17 |
| WO1994022831A1 (en) | 1994-10-13 |
| FI954645A0 (fi) | 1995-09-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IS5157A (is) | Arýlsúlfónamíð og hliðstæður þeirra og notkun þeirra við meðhöndlun taugahrörnunarsjúkdóma | |
| CY2009018I1 (el) | Φαρμακευτικη συνθεση περιλαμβανουσα πιογλιταζονη και γλιμεπιριδη για χρηση στην θεραπεια του διαβητη | |
| DK91793D0 (da) | Fremgangsmaade til overfladebehandling, midler til udoevelse og anvendelsen heraf | |
| DK1114821T3 (da) | Benzopyraner og disses anvendelse som terapeutiske midler | |
| NO953846L (no) | (S)-alfa-fenyl-2-pyridinetanamin (S)-malat og dets anvendelse som legemiddel | |
| MY129643A (en) | Tablet comprising cetirizine and pseudoephedrine | |
| AU5963396A (en) | Cis-resorcylide, pharmaceutical composition containing it, use thereof in the treatment of thrombosis and related disorders | |
| ITMI930341A1 (it) | Impiego terapeutico del pirrolidon carbossilato di piridossina | |
| DK0691958T3 (da) | (S)-alfa-phenyl-2-pyridinethanaminbenzoat og dets anvendelse som et medikament | |
| ITRM940140A0 (it) | Procedimento e dispositivo per la produzione di potassa. | |
| FR2691359B1 (fr) | Nouvelle application therapeutique du malate de 1-citrulline. | |
| FR2694702B3 (fr) | Bracelet therapeutique perfectionne. | |
| ID15808A (id) | Penggunaan protease dibidang kedokteran | |
| ITFI920241A0 (it) | Impiego della melatonina nella terapia della sclerosi sistematica, della sarcoidosi ed altro | |
| PT8585T (pt) | Pulseira terapeutica aperfeicoada |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK1K | Patent expired |